The probability of blindness due to the serious eye disease glaucoma has decreased by nearly half since 1980, according to a new study. The researchers speculate that advances in diagnosis and therapy are likely causes for the decrease.
People who enjoy life maintain better physical function in their daily activities and keep up faster walking speeds as they age, compared with people who enjoy life less, according to a new study.
Researchers are set to decipher the genomes of a main bacterial cause of food poisoning, which results in over 21,000 hospital admissions and 100 deaths each year.
A large global team of reproduction experts has found a way to even the score for older women seeking pregnancy using a process called preimplantation genetic diagnosis (PGD).
A thickening of the brain cortex associated with regular meditation or other spiritual or religious practice could be the reason those activities guard against depression– particularly in people who are predisposed to the disease, according to new research.
Cancer cells have something that every prisoner longs for— a master key that allows them to escape. A study describes how a protein that promotes tumor growth also enables cancer cells to use this key and metastasize.
Researchers have decoded the genome of the hookworm, Necator americanus, finding clues to how it infects and survives in humans and to aid in development of new therapies to combat hookworm disease.
Researchers have identified a new molecular mechanism by which cocaine alters the brain's reward circuits and causes addiction. The research reveals how an enzyme and synaptic gene affect a key reward circuit in the brain, changing the ways genes are expressed.
As the country settles in for yet another winter full of colds and flu, imagine if your undershirt or socks not only kept you warm but also warned you about an oncoming infection.
Activation of a single type of neuron in the prefrontal cortex can spur a mouse to eat more— a finding that may pinpoint an elusive mechanism the human brain uses to regulate food intake.
Exposing skin to sunlight may help to reduce blood pressure by altering levels of the small messenger molecule nitric oxide (NO) in the skin and blood, thus cutting the risk of heart attack and stroke, a new study says.
As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones that are no longer effective. One promising new class of molecules called acyldepsipeptides — ADEPs — kills bacteria in a way that no marketed antibacterial drug does — by altering the pathway through which cells rid themselves of harmful proteins.
In 2009, the first face transplant was performed at Brigham and Women’s Hospital, and lead surgeon, Dr. Bohdan Pomahac has been pioneering the procedure since. However, understanding the challenges, particularly around how the recipient accepts or rejects the donated face, is just beginning. Following any transplant, including facial transplant, T cells in the recipient mount an immune response to the donated tissue, threatening rejection.
As scientists forecast the impacts of climate change, one missing piece of the puzzle is what will happen to the carbon in the soil and the microbes that control the fate of this carbon as the planet warms. Scientists studying grasslands in Oklahoma have discovered that an increase of 2 degrees Celsius in the air temperature above the soil creates significant changes to the microbial ecosystem underground.
A team of Australian researchers has taken a step towards controlling a growing problem in the wine community. They have identified special yeast that produce a lower level of alcohol, helping to preserve the flavor. The alcoholic content of wine has crept gradually northward in the last 10-15 years, from 12-12.5 percent to beyond 15 percent and is seen by some as a disturbing trend, threatening the flavor and character of some wines.
Gene therapies developed by University of Pennsylvania School of Veterinary Medicine researchers have worked to correct different forms of blindness. While effective, the downside to these approaches to vision rescue is that each disease requires its own form of gene therapy to correct the particular genetic mutation involved, a time consuming and complex process.
Google unveiled a contact lens that monitors glucose levels in tears, a potential reprieve for millions of diabetics who have to jab their fingers to draw their own blood as many as 10 times a day. The prototype, which Google says will take at least five years to reach consumers, is one of several medical devices being designed by companies to make glucose monitoring for diabetic patients more convenient.
Johnson & Johnson has been offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business, a year after J&J began reviewing strategic options for the blood-testing unit as part of a routine pruning of its extensive family of businesses. J&J has until March 31 to decide whether to accept the offer.
A major mystery in heart disease—why most people who develop serious heart disease have normal blood pressure and cholesterol—may have been solved in a “tremendously significant” study. Some are already calling the study “important” and “frame-shifting.” The study—Multi-Ethnic Study of Atherosclerosis—found that coronary artery calcium scans can often more accurately predict heart disease than cholesterol and blood pressure readings.
A small, preliminary study using gene therapy to treat a rare form of blindness is promising and could trigger similar efforts for other causes of vision loss, British doctors say. They studied just six patients. Of those, two have had dramatic improvements in their vision and none has reported any serious side effects. The study was only designed to test the treatment's safety, not its effectiveness.
The controversial notion that being overweight might actually be healthier for some people with diabetes — seems to be a myth, researchers report. A major study finds there's no survival advantage to being large, and a disadvantage to being very large.
Biotech drugmaker Amgen and Illumina, a maker of genetic testing equipment, said Wednesday they are developing a test that will identify patients who might be helped by Amgen's colon cancer drug Vectibix. Vectibix is approved as a treatment for colorectal cancer that has spread and hasn't rresponded to chemotherapy.
Immunotherapy—the art and science of training peoples’ immune systems to fight their own cancers—was named Breakthrough of the Year by Science. Prominently mentioned was an approach seeing clinical success: genetically tweaking patients’ own T cells to make them more potent, proliferative, and targeted.
Researchers at the University of Cincinnati (UC) have identified key molecular components linking circadian rhythms and cell division cycles in Neurospora crassa, providing insights that could lead to improved disease treatments and drug delivery.
A single molecule, which acts equally on the receptors of the metabolic hormones glucagon and glucagon-like peptide-1 (GLP-1) improves body weight and diabetes through restored function of the anti-obesity hormone leptin. Scientists found out that treatment of obese mice with this GLP-1/Glucagon co-agonist improves metabolism and body weight associated with restored function of the weight lowering hormone leptin.